Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-31

Clinical Trial Update: Coenzyme Q10 in Juvenile Idiopathic Arthritis Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigating Coenzyme Q10 in Juvenile Idiopathic Arthritis in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Nourhan Elsherif | Conditions: Juvenile Idiopathic Arthritis | Phase 2, Phase 3 | Status: UNKNOWN